Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
AVITA Medical Inc has a consensus price target of $24.25 based on the ratings of 5 analysts. The high is $40 issued by Lake Street on July 13, 2023. The low is $9 issued by Piper Sandler on May 14, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Piper Sandler, and Cantor Fitzgerald on August 9, 2024, May 14, 2024, and May 14, 2024, respectively. With an average price target of $17 between Cantor Fitzgerald, Piper Sandler, and Cantor Fitzgerald, there's an implied 92.31% upside for AVITA Medical Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for AVITA Medical (NASDAQ:RCEL) was reported by Cantor Fitzgerald on August 9, 2024. The analyst firm set a price target for $21.00 expecting RCEL to rise to within 12 months (a possible 137.56% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for AVITA Medical (NASDAQ:RCEL) was provided by Cantor Fitzgerald, and AVITA Medical reiterated their overweight rating.
There is no last upgrade for AVITA Medical
The last downgrade for AVITA Medical Inc happened on May 14, 2024 when Piper Sandler changed their price target from $21 to $9 for AVITA Medical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AVITA Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AVITA Medical was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.
While ratings are subjective and will change, the latest AVITA Medical (RCEL) rating was a reiterated with a price target of $21.00 to $21.00. The current price AVITA Medical (RCEL) is trading at is $8.84, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.